Part of the thing people cite in terms of BBRY's intrinsic value is its patents. In your opinion, are those patents outdated? Do they still have value?
The stock climbed substantially earlier in the week, seemingly before the European approval - what do you think accounts for that, and where do you see it leveling off in the near term?
Any chance you will do a more detailed article on Maestro? I saw it on the news recently and have been trying to educate myself even though weight loss stocks in general make me nervous...
I'm a little puzzled over the reasons Merck pulled out. What I can see in quick research is something about the size of the opportunity (ie not 'big enough' for Merck) and something about oral vs. intravenous. Is Cardiome focusing on one delivery method over the other now?
I enjoy your posts, but wish you would spend just a few extra moments to proof read them. You'd be able to get your point across so much better! You are very hard to follow. Thanks.
Latest Comments
Oil Inventories Continue To Rise But Gasoline Production Slowing
I'm thinking of putting aside the money I'm saving on gas to invest in something that would hedge my oil-impacted investments. Any suggestions?
Blackberry - Lost In Communication
Part of the thing people cite in terms of BBRY's intrinsic value is its patents. In your opinion, are those patents outdated? Do they still have value?
Novartis Wins FDA Approval In The U.S. To Sell Its Psoriasis Drug Cosentyx
The stock climbed substantially earlier in the week, seemingly before the European approval - what do you think accounts for that, and where do you see it leveling off in the near term?
2 Triple Digit Winners For Under $2
Any chance you will do a more detailed article on Maestro? I saw it on the news recently and have been trying to educate myself even though weight loss stocks in general make me nervous...
ATNM Submits CMC Meeting Request To FDA For Iomab-B; NBIX Announces Oral Presentation Of NBI-77860 Clinical Trial Data
I wish you did some analysis instead of just recycling press releases...
Cardiome Pharma: Why This Bio Gem Could Be An Easy Double This Year
I'm a little puzzled over the reasons Merck pulled out. What I can see in quick research is something about the size of the opportunity (ie not 'big enough' for Merck) and something about oral vs. intravenous. Is Cardiome focusing on one delivery method over the other now?
Guess What Happened The Last Time The Price Of Oil Crashed Like This
I enjoy your posts, but wish you would spend just a few extra moments to proof read them. You'd be able to get your point across so much better! You are very hard to follow. Thanks.
The Sound Of Money: The Musical! (Humor)
Very creative, this gave me a good laugh!
Forget About China… I’m Investing In India!
This is a good point that most people don't realize at first glance.